ProQR Therapeutics N.V.
(PRQR)
undefined
undefined%
At close: undefined
2.62
0.00%
After-hours Jan 06, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -27.54M | -64.89M | -61.68M | -46.61M | -56.75M | -37.09M | -43.52M | -39.12M | -20.83M | -12.13M | -3.25M |
| Depreciation & Amortization | 2.46M | 2.52M | 2.33M | 2.35M | 2.05M | 992.00K | 1.06M | 1.25M | 480.00K | 126.00K | 24.00K |
| Stock-Based Compensation | 3.11M | 2.87M | 6.22M | 7.84M | 9.11M | 3.22M | 4.02M | 2.45M | 1.21M | 646.00K | 41.00K |
| Other Working Capital | 48.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | -5.35M | -3.67M | 2.01M | -5.75M | -402.00K | 792.00K | 3.17M | -470.00K | -6.17M | -4.33M | 14.00K |
| Deferred Income Tax | -78.00K | 96.00K | 117.00K | 124.00K | 235.00K | 102.00K | 145.00K | 236.00K | 441.00K | 142.00K | 13.00K |
| Change in Working Capital | 48.96M | -5.43M | 25.00M | -5.01M | 1.78M | 1.29M | 164.00K | 1.43M | 637.00K | 1.09M | 829.00K |
| Operating Cash Flow | 21.55M | -68.51M | -26.01M | -47.06M | -43.97M | -30.68M | -34.95M | -34.22M | -24.23M | -14.46M | -2.33M |
| Capital Expenditures | -1.37M | -708.00K | -484.00K | -924.00K | -580.00K | -312.00K | -121.00K | -2.54M | -1.32M | -1.23M | -137.00K |
| Acquisitions | 58.77K | 5.89K | 61.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 7.86M | 108.06 | -2.35K | n/a | n/a | n/a | n/a | n/a | -28.00K | n/a | n/a |
| Investing Cash Flow | 4.28M | -702.00K | -425.00K | -924.00K | -580.00K | -312.00K | -121.00K | -2.54M | -1.32M | -1.23M | -137.00K |
| Debt Repayment | -2.63M | -45.05M | 26.84M | 13.77M | 1.46M | 1.40M | 951.00K | 355.00K | 1.61M | 1.63M | 3.33M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 354.00K | 34.00K | 1.52M | 735.00K | 193.00K | 870.00K | 4.00K | 2.00K | 14.00K | n/a | n/a |
| Financial Cash Flow | -2.27M | -30.89M | 136.83M | 14.50M | 50.20M | 88.65M | 26.64M | 357.00K | 1.62M | 119.88M | 6.35M |
| Net Cash Flow | 24.15M | -92.75M | 111.69M | -36.11M | 6.37M | 57.48M | -11.10M | -35.66M | -17.87M | 108.61M | 3.88M |
| Free Cash Flow | 20.18M | -69.22M | -26.50M | -47.98M | -44.55M | -30.99M | -35.07M | -36.76M | -25.56M | -15.69M | -2.47M |